These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 17553421)

  • 1. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.
    Reiman EM; Webster JA; Myers AJ; Hardy J; Dunckley T; Zismann VL; Joshipura KD; Pearson JV; Hu-Lince D; Huentelman MJ; Craig DW; Coon KD; Liang WS; Herbert RH; Beach T; Rohrer KC; Zhao AS; Leung D; Bryden L; Marlowe L; Kaleem M; Mastroeni D; Grover A; Heward CB; Ravid R; Rogers J; Hutton ML; Melquist S; Petersen RC; Alexander GE; Caselli RJ; Kukull W; Papassotiropoulos A; Stephan DA
    Neuron; 2007 Jun; 54(5):713-20. PubMed ID: 17553421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers.
    Liang WS; Chen K; Lee W; Sidhar K; Corneveaux JJ; Allen AN; Myers A; Villa S; Meechoovet B; Pruzin J; Bandy D; Fleisher AS; Langbaum JB; Huentelman MJ; Jensen K; Dunckley T; Caselli RJ; Kaib S; Reiman EM
    Neuroimage; 2011 Feb; 54(3):1896-902. PubMed ID: 20888920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.
    Ramirez-Lorca R; Boada M; Saez ME; Hernandez I; Mauleon A; Rosende-Roca M; Martinez-Lage P; Gutierrez M; Real LM; Lopez-Arrieta J; Gayan J; Antunez C; Gonzalez-Perez A; Tarraga L; Ruiz A
    J Nutr Health Aging; 2009 Mar; 13(3):214-9. PubMed ID: 19262956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAB2 is not associated with late-onset Alzheimer's disease in Chinese Han.
    Lin K; Tang M; Han H; Guo Y; Lin Y; Ma C
    Neurol Sci; 2010 Jun; 31(3):277-81. PubMed ID: 19924507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia.
    Sleegers K; Bettens K; Brouwers N; Engelborghs S; van Miegroet H; De Deyn PP; Van Broeckhoven C
    Hum Mutat; 2009 Feb; 30(2):E338-44. PubMed ID: 18853460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAB2 polymorphism rs2373115 confers susceptibility to sporadic Alzheimer's disease.
    Jin C; Wu CZ; Liu X; Zhang F; Tian L; Yuan J; Wang G; Cheng Z
    Neurosci Lett; 2013 Nov; 556():216-20. PubMed ID: 24161894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease.
    Nacmias B; Tedde A; Bagnoli S; Cellini E; Guarnieri BM; Piacentini S; Sorbi S
    J Alzheimers Dis; 2009; 16(3):513-5. PubMed ID: 19276544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
    Yu JT; Tan L; Ou JR; Zhu JX; Liu K; Song JH; Sun YP
    Brain Res; 2008 May; 1210():216-22. PubMed ID: 18423577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
    Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
    Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
    Jiang S; Yang W; Qiu Y; Chen HZ;
    Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GAB2 and BDNF polymorphisms and the risk for late-onset Alzheimer's disease in an elderly Brazilian sample.
    Vieira RN; Magalhães JD; Sant'Anna J; Moriguti MM; de Paula JJ; Cintra MT; de Miranda DM; De Marco L; de Moraes EN; Romano-Silva MA; Bicalho MA
    Int Psychogeriatr; 2015 Oct; 27(10):1687-92. PubMed ID: 25853819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAB2 is not associated with late-onset Alzheimer's disease in Japanese.
    Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Kuwano R
    Eur J Hum Genet; 2009 May; 17(5):682-6. PubMed ID: 18854865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology.
    Zou F; Belbin O; Carrasquillo MM; Culley OJ; Hunter TA; Ma L; Bisceglio GD; Allen M; Dickson DW; Graff-Radford NR; Petersen RC; ; Morgan K; Younkin SG
    PLoS One; 2013; 8(5):e64802. PubMed ID: 23724096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain.
    Green EK; Thaker U; McDonagh AM; Iwatsubo T; Lambert JC; Chartier-Harlin MC; Harris JM; Pickering-Brown SM; Lendon CL; Mann DM
    Neurosci Lett; 2002 May; 324(2):113-6. PubMed ID: 11988340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
    Malek-Ahmadi M; Beach T; Obradov A; Sue L; Belden C; Davis K; Walker DG; Lue L; Adem A; Sabbagh MN
    Curr Alzheimer Res; 2013 Jul; 10(6):654-9. PubMed ID: 23627755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype.
    Izzo G; Forlenza OV; Santos Bd; Bertolucci PH; Ojopi EB; Gattaz WF; Kerr DS
    Clinics (Sao Paulo); 2013; 68(2):277-80. PubMed ID: 23525328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese.
    Chen DW; Yang JF; Tang Z; Dong XM; Feng XL; Yu S; Chan P
    Brain Res; 2008 Jan; 1187():52-7. PubMed ID: 18036514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis.
    Ikram MA; Liu F; Oostra BA; Hofman A; van Duijn CM; Breteler MM
    Biol Psychiatry; 2009 Jun; 65(11):995-9. PubMed ID: 19118819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.